Spots Global Cancer Trial Database for thyroid carcinoma
Every month we try and update this database with for thyroid carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy | NCT04554680 | Thyroid Cancer | dabrafenib and ... | 21 Years - 99 Years | National University Hospital, Singapore | |
Function Integrity of Neck Anatomy in Thyroid Surgery | NCT04666103 | Thyroid Carcino... Thyroid Nodule ... Ablation; Retin... | Intraoperative ... | 18 Years - 75 Years | Wuhan University | |
Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma | NCT01813136 | Thyroid Carcino... | Continuous pazo... Intermittent pa... | 18 Years - | Centre Leon Berard | |
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer | NCT00507429 | Anaplastic Thyr... | CA4P paclitaxel carboplatin | 18 Years - | Mateon Therapeutics | |
A Study Into the Effect of Seprafilm in Open Total Thyroidectomy | NCT01865838 | Thyroid Carcino... | Seprafilm (Sano... | 21 Years - 75 Years | National Cancer Centre, Singapore | |
Study of External Beam Radiotherapy to Thyroid Carcinoma | NCT01173289 | Thyroid Cancer | External Beam R... | 18 Years - | National Cancer Center, Korea | |
Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer | NCT00647140 | Thyroid Neoplas... Thyroid Carcino... Medullary Carci... | 18F-L-DOPA PET | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW | NCT06095362 | Thyroid Carcino... Surgery | Bevacizumab-IRD... | 18 Years - | University Medical Center Groningen | |
Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine | NCT02773667 | Thyroid Carcino... | 18 Years - | Jena University Hospital | ||
Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer | NCT04624477 | Papillary Thyro... Papillary Thyro... Papillary Micro... | 18 Years - | University Health Network, Toronto | ||
Prospective Multicenter Study on Clinical Application of Sonozoid in Thyroid Tumor | NCT04574258 | Ultrasound | 18 Years - | Chinese PLA General Hospital | ||
Management of Indeterminate Thyroid Nodules Across Different World Regions | NCT05851404 | Indeterminate T... | Thyroidectomy | - | University of Cagliari | |
Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma | NCT02648399 | Thyroid Papilla... | surgery:BCND(bi... surgery:UCND(un... | 15 Years - 60 Years | Fujian Medical University | |
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) | NCT03157128 | Non-Small Cell ... Medullary Thyro... Colon Cancer Any Solid Tumor | LOXO-292 | 12 Years - | Eli Lilly and Company | |
Impact of the COVID-19 Pandemic on Surgery for Thyroid Cancer | NCT05178186 | Thyroid Carcino... | Thyroidectomy | 18 Years - | University of Cagliari | |
The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma | NCT01707056 | Thyroid Carcino... Hypothyroidism | Black Coffee Coffee with Mil... Black Tea Water | 18 Years - 60 Years | Medstar Health Research Institute | |
Changes in Metabolic Status in Patients With Total Thyroidectomy | NCT01781767 | Thyroid Cancer | 18 Years - 65 Years | Tel-Aviv Sourasky Medical Center | ||
Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases | NCT00749697 | Thyroid Carcino... Metastatic Site... | SPECT scan | 18 Years - | Royal Marsden NHS Foundation Trust | |
Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies | NCT00215605 | Lymphoma Cancer Thyroid Carcino... | XL184 | 18 Years - | Exelixis | |
Study of External Beam Radiotherapy to Thyroid Carcinoma | NCT01173289 | Thyroid Cancer | External Beam R... | 18 Years - | National Cancer Center, Korea | |
Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer | NCT01083550 | Thyroid Cancer | Decision aid ex... | 18 Years - | University Health Network, Toronto | |
Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer | NCT00647140 | Thyroid Neoplas... Thyroid Carcino... Medullary Carci... | 18F-L-DOPA PET | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW | NCT06095362 | Thyroid Carcino... Surgery | Bevacizumab-IRD... | 18 Years - | University Medical Center Groningen | |
CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma | NCT06146764 | Thyroid Nodule Thyroid Carcino... | Contrast-enhanc... | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
Impact of the COVID-19 Pandemic on Surgery for Thyroid Cancer | NCT05178186 | Thyroid Carcino... | Thyroidectomy | 18 Years - | University of Cagliari | |
International PPB/DICER1 Registry | NCT03382158 | Pleuropulmonary... Sertoli-Leydig ... DICER1 Syndrome Cystic Nephroma Wilms Tumor Pineoblastoma Renal Sarcoma Nodular Hyperpl... Nasal Chondrome... Ciliary Body Me... Neuroblastoma Pituitary Cance... Embryonal Rhabd... Ovarian Sarcoma Gynandroblastom... Thyroid Carcino... Embryonal Rhabd... Embryonal Rhabd... Embryonal Rhabd... | - | Children's Hospitals and Clinics of Minnesota | ||
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer | NCT00507429 | Anaplastic Thyr... | CA4P paclitaxel carboplatin | 18 Years - | Mateon Therapeutics | |
Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine | NCT02773667 | Thyroid Carcino... | 18 Years - | Jena University Hospital | ||
A Study Into the Effect of Seprafilm in Open Total Thyroidectomy | NCT01865838 | Thyroid Carcino... | Seprafilm (Sano... | 21 Years - 75 Years | National Cancer Centre, Singapore | |
Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer | NCT02658513 | Cancer of the T... Cancer of Thyro... Thyroid Cancer Thyroid Carcino... | Lancet blood sa... Standard intrav... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
Management of Indeterminate Thyroid Nodules Across Different World Regions | NCT05851404 | Indeterminate T... | Thyroidectomy | - | University of Cagliari | |
Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Drain | NCT01126060 | Thyroid Carcino... Thyroidectomy | Usage of Fibrin... Thyroidectomy | 20 Years - 80 Years | Samsung Medical Center | |
Cell-free Tumor DNA in Head and Neck Cancer Patients | NCT03942380 | Head and Neck C... Head and Neck N... Head and Neck S... Oropharynx Canc... Oropharynx Neop... Oropharynx Carc... Oral Cavity Can... Oral Cancer Oral Neoplasm Larynx Cancer Larynx Carcinom... Larynx Neoplasm Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Neo... Hypopharynx Can... Hypopharynx Neo... Hypopharynx Car... Sinonasal Carci... Thyroid Carcino... Thyroid Cancer Thyroid Neoplas... Salivary Gland ... Salivary Gland ... Salivary Gland ... Sinonasal Cance... Sinonasal Neopl... | Liquid biopsy | 18 Years - | Rigshospitalet, Denmark | |
Thyroid Cancer and Sunitinib | NCT00510640 | Cancer Thyroid Carcino... | Sunitinib | 18 Years - | University Hospital, Bordeaux | |
Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer | NCT01083550 | Thyroid Cancer | Decision aid ex... | 18 Years - | University Health Network, Toronto | |
Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer | NCT01083550 | Thyroid Cancer | Decision aid ex... | 18 Years - | University Health Network, Toronto | |
Comparative Study of Robot BABA Approach and Chest Breast Approach for Lateral Neck Dissection | NCT03500666 | Thyroid Carcino... Robot Surgery Endoscopic Surg... | Robot Total endoscopi... | 18 Years - 70 Years | Fujian Medical University | |
Trial of LBH589 in Metastatic Thyroid Cancer | NCT01013597 | Thyroid Carcino... | LBH589 | 18 Years - | University of Wisconsin, Madison | |
OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation | NCT00439127 | Differentiated ... | - | Oncology Institute of Southern Switzerland | ||
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer | NCT00507429 | Anaplastic Thyr... | CA4P paclitaxel carboplatin | 18 Years - | Mateon Therapeutics | |
International PPB/DICER1 Registry | NCT03382158 | Pleuropulmonary... Sertoli-Leydig ... DICER1 Syndrome Cystic Nephroma Wilms Tumor Pineoblastoma Renal Sarcoma Nodular Hyperpl... Nasal Chondrome... Ciliary Body Me... Neuroblastoma Pituitary Cance... Embryonal Rhabd... Ovarian Sarcoma Gynandroblastom... Thyroid Carcino... Embryonal Rhabd... Embryonal Rhabd... Embryonal Rhabd... | - | Children's Hospitals and Clinics of Minnesota | ||
Assessment the Cancer Risk of Indeterminate Thyroid Nodules Through Integration of Clinical, Ultrasonographic and Multiomic Features | NCT05428371 | Thyroid Nodule Thyroid Cancer | Multiomic analy... | 18 Years - | University of Cagliari | |
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma | NCT01813136 | Thyroid Carcino... | Continuous pazo... Intermittent pa... | 18 Years - | Centre Leon Berard | |
Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy | NCT04554680 | Thyroid Cancer | dabrafenib and ... | 21 Years - 99 Years | National University Hospital, Singapore | |
Prospective Multicenter Study on Clinical Application of Sonozoid in Thyroid Tumor | NCT04574258 | Ultrasound | 18 Years - | Chinese PLA General Hospital | ||
Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal. | NCT00001730 | Hypothyroidism Thyroid Neoplas... | Thyrogen | - | National Institutes of Health Clinical Center (CC) | |
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | NCT02628067 | Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc... | pembrolizumab pembrolizumab | 18 Years - | Merck Sharp & Dohme LLC | |
Feasibility of Endoscopic Thyroidectomy for Thyroid Carcinoma | NCT00993837 | Thyroid Carcino... | thyroidectomy | 18 Years - 45 Years | Second Military Medical University | |
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | NCT02628067 | Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc... | pembrolizumab pembrolizumab | 18 Years - | Merck Sharp & Dohme LLC | |
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC | NCT05668962 | Thyroid Cancer Thyroid Carcino... Metastatic Thyr... Follicular Thyr... Unresectable Th... Papillary Thyro... | Selpercatinib Sodium Iodine I... rhTSH | 12 Years - | Massachusetts General Hospital | |
Influence of Thyroid Hormones on the Woundhealing Process | NCT00929318 | Thyroid Neoplas... Thyroid Carcino... | blood sampling blood sampling | 18 Years - | Hannover Medical School | |
European Multicenter Study on Surgical Management of Advanced Thyroid Cancer | NCT05796960 | Thyroid Carcino... Thyroid Cancer Thyroid Neoplas... Thyroid Cancer,... Thyroid Cancer,... Thyroid Medulla... Anaplastic Thyr... | Thyroidectomy w... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis) | NCT02156362 | Thyroid Cancer | follow up visit | 18 Years - | Hospices Civils de Lyon | |
Function Integrity of Neck Anatomy in Thyroid Surgery | NCT04666103 | Thyroid Carcino... Thyroid Nodule ... Ablation; Retin... | Intraoperative ... | 18 Years - 75 Years | Wuhan University | |
Thyroid Cancer and Sunitinib | NCT00510640 | Cancer Thyroid Carcino... | Sunitinib | 18 Years - | University Hospital, Bordeaux | |
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
Lipid Metabolic Status in Thyroid Carcinoma | NCT01487057 | Thyroid Carcino... Dyslipidemias Risk Reduction ... Hormone Replace... | 18 Years - 80 Years | Prof. Dr. I. Chiricuta Institute of Oncology | ||
Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis) | NCT02156362 | Thyroid Cancer | follow up visit | 18 Years - | Hospices Civils de Lyon | |
Management of Indeterminate Thyroid Nodules Across Different World Regions | NCT05851404 | Indeterminate T... | Thyroidectomy | - | University of Cagliari | |
Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function | NCT02194920 | Thyroid Goiter Thyroid Carcino... Multinodular Go... Graves Diseases | Thyroidectomy a... | - | University of Roma La Sapienza | |
More Than 50% of the Patients With Clinically Unifocal T1b/Small T2 Node Negative Papillary Thyroid Carcinoma Scheduled for Thyroid Lobectomy May Require Completion Thyroidectomy if the Nodal Status is Evaluated | NCT06439745 | Papillary Thyro... Papillary Carci... Thyroid Cancer Thyroid Carcino... Thyroid Cancer,... Lymph Node Meta... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | ||
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | NCT02628067 | Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc... | pembrolizumab pembrolizumab | 18 Years - | Merck Sharp & Dohme LLC | |
Cell-free Tumor DNA in Head and Neck Cancer Patients | NCT03942380 | Head and Neck C... Head and Neck N... Head and Neck S... Oropharynx Canc... Oropharynx Neop... Oropharynx Carc... Oral Cavity Can... Oral Cancer Oral Neoplasm Larynx Cancer Larynx Carcinom... Larynx Neoplasm Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Neo... Hypopharynx Can... Hypopharynx Neo... Hypopharynx Car... Sinonasal Carci... Thyroid Carcino... Thyroid Cancer Thyroid Neoplas... Salivary Gland ... Salivary Gland ... Salivary Gland ... Sinonasal Cance... Sinonasal Neopl... | Liquid biopsy | 18 Years - | Rigshospitalet, Denmark | |
Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy | NCT04554680 | Thyroid Cancer | dabrafenib and ... | 21 Years - 99 Years | National University Hospital, Singapore | |
Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System | NCT04327999 | Thyroid Carcino... Radioactive Iod... | Artificial Tear... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer | NCT02658513 | Cancer of the T... Cancer of Thyro... Thyroid Cancer Thyroid Carcino... | Lancet blood sa... Standard intrav... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm | NCT01433809 | Cancer of the T... Neoplasms, Thyr... Thyroid Adenoma Thyroid Cancer Thyroid Carcino... | 18 Years - 90 Years | Mayo Clinic |